India is an attractive target for pharmaceutical companies and other clinical research providers. India promises access to more patients, in greater concentrations, than most other markets, as well as the opportunity to establish trials with treatment-naïve patients.
https://www.bharatbook.com/events/3rd-annual-pharma-regulatory-summit-2020/18